Digestive Disease Interventions 2017; 01(04): 272-276
DOI: 10.1055/s-0038-1629917
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA

Early Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement in Patients with Cirrhosis and Variceal Bleeding

Min Lang
1   School of Medicine, Case Western Reserve University, Cleveland, Ohio
,
Brett E. Fortune
2   Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York
,
Mark J. Sands
3   Department of Interventional Radiology, Imaging Institute, Cleveland Clinic, Cleveland, Ohio
,
Maria Del Pilar Bayona-Molano
3   Department of Interventional Radiology, Imaging Institute, Cleveland Clinic, Cleveland, Ohio
,
Baljendra S. Kapoor
3   Department of Interventional Radiology, Imaging Institute, Cleveland Clinic, Cleveland, Ohio
› Author Affiliations
Further Information

Publication History

13 November 2017

03 January 2018

Publication Date:
14 February 2018 (online)

Abstract

The placement of a transjugular intrahepatic portosystemic shunt (TIPS) has been traditionally used as a rescue treatment for uncontrolled or recurrent acute variceal bleeding (AVB) in patients with cirrhosis. However, more contemporary studies are revealing that early or ‘pre-emptive’ TIPS placement (performed within 24–72 h of AVB presentation) significantly controls bleeding, prevents rebleeding, and improves survival in selected patients when compared with standard pharmacological and endoscopic therapies. Furthermore, the use of early TIPS did not translate to an increased risk of hepatic encephalopathy (HE) for this population. Proper patient selection for early TIPS is paramount, as the procedure is unlikely to benefit patients with advanced decompensated cirrhosis (Child–Turcotte–Pugh [CTP] class C, score > 13) or patients who do not carry high risk with only mild hepatic dysfunction (Child-Turcotte-Pugh class A). Finally, while the current results for early TIPS are promising, further prospective studies are needed to confirm these findings before early TIPS can be widely adopted.

 
  • References

  • 1 Rösch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 1969; 92 (05) 1112-1114
  • 2 Richter GM, Palmaz JC, Nöldge G. , et al. [The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method]. Radiologe 1989; 29 (08) 406-411
  • 3 Colapinto RF, Stronell RD, Birch SJ. , et al. Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter. Can Med Assoc J 1982; 126 (03) 267-268
  • 4 Barrio J, Ripoll C, Bañares R. , et al. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents. Eur J Radiol 2005; 55 (01) 120-124
  • 5 Charon JP, Alaeddin FH, Pimpalwar SA. , et al. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2004; 15 (11) 1219-1230
  • 6 Hausegger KA, Karnel F, Georgieva B. , et al. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol 2004; 15 (03) 239-248
  • 7 Angeloni S, Merli M, Salvatori FM. , et al. Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results. Am J Gastroenterol 2004; 99 (02) 280-285
  • 8 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44 (01) 217-231
  • 9 Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008; 48 (Suppl. 01) S68-S92
  • 10 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD. ; Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 2007; 102 (09) 2086-2102
  • 11 Moitinho E, Escorsell A, Bandi JC. , et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117 (03) 626-631
  • 12 Ripoll C, Bañares R, Rincón D. , et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology 2005; 42 (04) 793-801
  • 13 Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. Portal hypertension and gastrointestinal bleeding. Semin Liver Dis 2008; 28 (01) 3-25
  • 14 D'Amico G, De Franchis R. ; Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38 (03) 599-612
  • 15 Krige JE, Kotze UK, Distiller G, Shaw JM, Bornman PC. Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis. World J Surg 2009; 33 (10) 2127-2135
  • 16 Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology 2008; 134 (06) 1715-1728
  • 17 Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80 (04) 800-809
  • 18 Villanueva C, Piqueras M, Aracil C. , et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol 2006; 45 (04) 560-567
  • 19 Abraldes JG, Villanueva C, Bañares R. , et al; Spanish Cooperative Group for Portal Hypertension and Variceal Bleeding. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 2008; 48 (02) 229-236
  • 20 Bosch J, Thabut D, Albillos A. , et al; International Study Group on rFVIIa in UGI Hemorrhage. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial. Hepatology 2008; 47 (05) 1604-1614
  • 21 Boyer TD, Haskal ZJ. ; American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41 (02) 386-400
  • 22 Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol 2014; 31 (03) 235-242
  • 23 Triantos C, Vlachogiannakos J, Manolakopoulos S, Burroughs A, Avgerinos A. Is banding ligation for primary prevention of variceal bleeding as effective as beta-blockers, and is it safe?. Hepatology 2006; 43 (01) 196-197 , discussion 197–198
  • 24 Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology 2003; 124 (06) 1700-1710
  • 25 Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Interv Radiol 2005; 16 (05) 615-629
  • 26 Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology 1999; 30 (03) 612-622
  • 27 Azoulay D, Castaing D, Majno P. , et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001; 35 (05) 590-597
  • 28 Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L. , et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004; 40 (04) 793-801
  • 29 García-Pagán JC, Caca K, Bureau C. , et al; Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362 (25) 2370-2379
  • 30 Garcia-Pagán JC, Di Pascoli M, Caca K. , et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol 2013; 58 (01) 45-50
  • 31 Rudler M, Poynard T, Thabut D. Early use of TIPS for cirrhosis and variceal bleeding. N Engl J Med 2010; 363 (14) 1375 , author reply 1376
  • 32 Halabi SA, Sawas T, Sadat B. , et al. Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2016; 31 (09) 1519-1526
  • 33 Deltenre P, Trépo E, Rudler M. , et al. Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials. Eur J Gastroenterol Hepatol 2015; 27 (09) e1-e9
  • 34 Harman DJ, McCorry RB, Jacob RP. , et al. Economic modelling of early transjugular intrahepatic portosystemic shunt insertion for acute variceal haemorrhage. Eur J Gastroenterol Hepatol 2013; 25 (02) 201-207
  • 35 Child CGTJ. Surgery and portal hypertension. The Liver and Portal Hypertension. Philadelphia: Saunders; 1964: 50-64
  • 36 Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60 (08) 646-649
  • 37 Richter GM, Noeldge G, Palmaz JC, Roessle M. The transjugular intrahepatic portosystemic stent-shunt (TIPSS): results of a pilot study. Cardiovasc Intervent Radiol 1990; 13 (03) 200-207
  • 38 Richter GM, Noeldge G, Palmaz JC. , et al. Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology 1990; 174 (3 Pt 2): 1027-1030
  • 39 Haskal ZJ, Rees CR, Ring EJ, Saxon R, Sacks D. ; Technology Assessment Committee of the SCVIR. Reporting standards for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1997; 8 (02) 289-297
  • 40 de Franchis R. ; Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53 (04) 762-768
  • 41 Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy 2002; 34 (09) 690-697
  • 42 Pomier-Layrargues G, Villeneuve JP, Deschênes M. , et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001; 48 (03) 390-396
  • 43 García-Villarreal L, Martínez-Lagares F, Sierra A. , et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999; 29 (01) 27-32
  • 44 Merli M, Salerno F, Riggio O. , et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology 1998; 27 (01) 48-53
  • 45 Jalan R, Forrest EH, Stanley AJ. , et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997; 26 (05) 1115-1122
  • 46 Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997; 113 (05) 1623-1631
  • 47 Cello JP, Ring EJ, Olcott EW. , et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997; 126 (11) 858-865
  • 48 Cabrera J, Maynar M, Granados R. , et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996; 110 (03) 832-839
  • 49 Conejo I, Guardascione MA, Tandon P. , et al. Multicenter external validation of risk stratification criteria for patients with variceal bleeding. Clin Gastroenterol Hepatol 2018; 16 (01) 132-139.e8
  • 50 Garcia-Tsao G. Management of acute variceal hemorrhage as a model of individualized care for patients with cirrhosis. Clin Gastroenterol Hepatol 2018; 16 (01) 24-26
  • 51 Cichoż-Lach H, Michalak A. Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. World J Gastroenterol 2013; 19 (01) 26-34
  • 52 Luca A, D'Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999; 212 (02) 411-421
  • 53 Escorsell A, Bañares R, García-Pagán JC. , et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002; 35 (02) 385-392
  • 54 Rosado B, Kamath PS. Transjugular intrahepatic portosystemic shunts: an update. Liver Transpl 2003; 9 (03) 207-217